Triglimimark-1 mg Tablet

Composition of Triglimimark-1 mg Tablet

Triglimimark-1 mg Tablet contains Glimepiride 1 mg. It belongs to the Sulfonylurea class of medicines.

Uses of Triglimimark-1 mg Tablet

Type 2 diabetes mellitus (to control blood glucose) when diet and exercise alone are not sufficient; may be used alone or with other antidiabetic medicines as prescribed.

Key benefits

• Lowers fasting and post-meal blood glucose
• Improves glycaemic control in type 2 diabetes
• Helps reduce symptoms of high blood sugar
• Can be used alone or in combination as advised

How Triglimimark-1 mg Tablet works

Glimepiride is a sulfonylurea that stimulates pancreatic beta cells to release insulin. It also helps improve peripheral utilization of glucose, thereby lowering blood sugar levels.

How to take Triglimimark-1 mg Tablet

Tablet for oral use. Take exactly as prescribed, usually once daily with breakfast or the first main meal; swallow whole with water. Do not skip meals after taking; monitor blood glucose regularly.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.

If you take too much

An overdose of this medicine can cause severe and prolonged low blood sugar, which may lead to fits or unconsciousness. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Triglimimark-1 mg Tablet

Most side effects of Triglimimark-1 mg are mild and settle as the body adjusts. Reported side effects include:

• Hypoglycaemia (low blood sugar)
• dizziness
• headache
• nausea
• stomach upset
• diarrhoea
• weight gain
• skin rash

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Triglimimark-1 mg Tablet

Warnings and precautions

Risk of hypoglycaemia increased with missed meals, excessive exercise, alcohol, or dose changes; carry a fast-acting sugar source. Use with caution in elderly, malnourished patients, and in kidney or liver impairment. Tell your doctor if you have G6PD deficiency (risk of haemolysis), adrenal/pituitary insufficiency, or if you are ill, fasting, or undergoing surgery (dose adjustment may be needed). Seek medical help for severe hypoglycaemia, allergic reactions, jaundice or dark urine. Not for type 1 diabetes or diabetic ketoacidosis.

Do not take Triglimimark-1 mg if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for type 1 diabetes or for diabetic ketoacidosis. Not for people with severe kidney or liver disease.

Interactions with other medicines

Alcohol, insulin and other antidiabetics (e.g., metformin, DPP-4 inhibitors) (increased hypoglycaemia risk), beta-blockers (may mask hypoglycaemia symptoms), fluoroquinolones, azole antifungals (e.g., fluconazole), macrolides (e.g., clarithromycin), sulfonamides, NSAIDs, warfarin, ACE inhibitors, corticosteroids, thiazide/loop diuretics, thyroid hormones, rifampicin, phenytoin

How to store Triglimimark-1 mg Tablet

Store below 25°C in a dry place, protected from light and moisture. Keep out of reach of children.

Expert advice for Triglimimark-1 mg Tablet

Take it shortly before a meal, and eat that meal. Check your sugar as often as your doctor has asked, especially when your routine changes.

Manufacturer and class

Manufacturer:

RISEMARKER PHARMACEUTICALS

Therapeutic class:

Antidiabetic

Drug class:

Sulfonylurea